Impact of a drug safety communication on the severity of benzonatate exposures reported to poison centers.

James Brewer LeonardHyunuk SeungWendy Klein-Schwartz

Published in: Pharmacoepidemiology and drug safety (2020)

Publication of a Drug Safety Communication regarding the risks of benzonatate did not result in a decrease in the proportion of severe benzonatate poisoning reported to US poison centers. Deaths and other severe outcomes continued to occur at a similar rate after the publication.

Keyphrases

drug induced
early onset
air pollution
adverse drug
human health
type diabetes
metabolic syndrome
risk assessment
adipose tissue
insulin resistance
skeletal muscle